Exclusive-Novo Nordisk's US public affairs head leaves company, memo shows
By Maggie Fick and Dan Levine LONDON/SAN FRANCISCO, Jan 5 (Reuters) - Danish obesity drugmaker Novo...
5th January, 2026
By Maggie Fick and Dan Levine LONDON/SAN FRANCISCO, Jan 5 (Reuters) - Danish obesity drugmaker Novo...
5th January, 2026
LONDON, Jan 5 (Reuters) - Britain's medicines regulator said on Monday it was reviewing Novo Nordisk...
5th January, 2026
COPENHAGEN, Jan 5 (Reuters) - Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weigh...
5th January, 2026
Dec 29 (Reuters) - Danish drugmaker Novo Nordisk has nearly halved prices of its obesity drug Wegovy...
29th December, 2025
HYDERABAD, India, Dec 24 (Reuters) - Global pharma giants Eli Lilly and Novo Nordisk are scrambling...
24th December, 2025
Dec 23 (Reuters) - Norwegian biathlete Johan-Olav Botn is looking to follow in the footsteps of his...
23rd December, 2025
Dec 23 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to win share in...
23rd December, 2025
Dec 23 (Reuters) - Novo Nordisk's Frankfurt-listed shares opened nearly 10% higher in early trading...
23rd December, 2025
Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on...
22nd December, 2025
LONDON, Dec 22 (Reuters) - Britain's health minister Wes Streeting said he would do everything he ca...
22nd December, 2025
ZURICH, Dec 20 (Reuters) - Deals between pharmaceutical companies and Washington to reduce prices fo...
20th December, 2025
WASHINGTON, Dec 19 (Reuters) - U.S. President Donald Trump said he does not plan to unveil a broader...
19th December, 2025